BrightBid Group AB (publ) Cash Flow Conversion Efficiency
BrightBid Group AB (publ) cash flow conversion efficiency. Based on the latest financial reports, BrightBid Group AB (publ) (PERP-B) has a cash flow conversion efficiency ratio of -0.071x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.03 Million ≈ $-218.68K USD) by net assets (Skr28.54 Million ≈ $3.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of BrightBid Group AB (publ) (2012–2025)
Cash flow conversion efficiency of BrightBid Group AB (publ) from 2012 to 2025. This chart illustrates how BrightBid Group AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View BrightBid Group AB (publ) stock quote for real-time trading data and today's change.
BrightBid Group AB (publ) Cash Flow Conversion Ratio Explained
BrightBid Group AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
BrightBid Group AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BrightBid Group AB (publ) ranked by their cash flow conversion efficiency. Also see PERP-B company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yangaroo Inc
V:YOO
|
0.540x |
|
Mercia Technologies PLC
LSE:MERC
|
0.032x |
|
Tivic Health Systems Inc
NASDAQ:TIVC
|
-0.453x |
|
ModuLink Inc.
NASDAQ:MDLK
|
-1.967x |
|
Lazydays Holdings Inc
NASDAQ:GORV
|
0.889x |
|
Triangle Energy (Global) Ltd
AU:TEG
|
3.581x |
|
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB
|
-0.119x |
|
BioSenic S.A.
BR:BIOS
|
0.059x |
Annual Cash Flow Conversion Efficiency for BrightBid Group AB (publ) (2012–2025)
The table below shows the annual cash flow conversion efficiency of BrightBid Group AB (publ) from 2012 to 2025. Review free cash flow generation of BrightBid Group AB (publ) to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr30.77 Million ≈ $3.31 Million |
Skr-5.46 Million ≈ $-587.91K |
-0.178x | +72.55% |
| 2024-12-31 | Skr10.87 Million ≈ $1.17 Million |
Skr-7.03 Million ≈ $-756.25K |
-0.647x | +68.19% |
| 2023-12-31 | Skr8.07 Million ≈ $868.57K |
Skr-16.41 Million ≈ $-1.77 Million |
-2.033x | -48.69% |
| 2022-12-31 | Skr14.03 Million ≈ $1.51 Million |
Skr-19.19 Million ≈ $-2.06 Million |
-1.368x | -85.77% |
| 2021-12-31 | Skr20.83 Million ≈ $2.24 Million |
Skr-15.34 Million ≈ $-1.65 Million |
-0.736x | -7.92% |
| 2020-12-31 | Skr14.97 Million ≈ $1.61 Million |
Skr-10.21 Million ≈ $-1.10 Million |
-0.682x | +16.19% |
| 2019-12-31 | Skr17.03 Million ≈ $1.83 Million |
Skr-13.86 Million ≈ $-1.49 Million |
-0.814x | -1.25% |
| 2018-12-31 | Skr13.72 Million ≈ $1.48 Million |
Skr-11.03 Million ≈ $-1.19 Million |
-0.804x | +3.28% |
| 2017-12-31 | Skr11.24 Million ≈ $1.21 Million |
Skr-9.34 Million ≈ $-1.01 Million |
-0.831x | +88.04% |
| 2016-12-31 | Skr1.32 Million ≈ $141.82K |
Skr-9.16 Million ≈ $-985.37K |
-6.948x | -555.55% |
| 2015-12-31 | Skr5.53 Million ≈ $595.30K |
Skr-5.86 Million ≈ $-630.95K |
-1.060x | -485.35% |
| 2014-12-31 | Skr6.12 Million ≈ $659.05K |
Skr-1.11 Million ≈ $-119.34K |
-0.181x | +12.07% |
| 2013-12-31 | Skr4.21 Million ≈ $453.06K |
Skr-867.00K ≈ $-93.30K |
-0.206x | -263.26% |
| 2012-12-31 | Skr4.06 Million ≈ $436.60K |
Skr-230.00K ≈ $-24.75K |
-0.057x | -- |
About BrightBid Group AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of dr… Read more